About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Seattle | 545 Studies

Clinical Trials Breast CancerSeattle

Breast Cancer Clinical Trials in Seattle

Find 545 clinical trials for breast cancer near Seattle, Washington. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Seattle

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 201-220 of 545 trials

Active not recruitingDeveloping an Internet-Delivered Sexual Health Program for Breast Cancer Survivors, SHINE TrialThe goal of this clinical trial is to develop an effective internet-delivered program to help breast cancer survivors manage cancer-related sexual concerns.NCT06216574·Phoenix, Arizona and 235 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingNivolumab and Ipilimumab in Treating Patients With Rare TumorsThis phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors.NCT02834013·Birmingham, Alabama and 1006 others

CompletedInterleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid TumorsRATIONALE: Interleukin-11 and filgrastim stimulate the production of blood cells.NCT00004157·Seattle, Washington

CompletedA Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast CancerThe purpose of this study is to evaluate the effectiveness of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus physicians choice standard of care…NCT02675231·Bakersfield, California and 92 others

RecruitingA Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyThis is a Phase III open-label study to assess if camizestrant improves outcomes compared to standard endocrine therapy in patients with ER+/HER2 - early breast cancer with…NCT05774951·Birmingham, Alabama and 708 others

CompletedVorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor TherapyThis pilot clinical trial studies vorinostat in treating patients with stage IV breast cancer receiving aromatase inhibitor (AI) therapy.NCT01153672·Seattle, Washington

Active not recruitingA Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast CancerA phase III, multicenter, randomized, open-label trial to evaluate the efficacy and safety of ribociclib with Endocrine Therapy (ET) as an adjuvant treatment in women and men with…NCT03701334·Birmingham, Alabama and 386 others

CompletedS0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast CancerRATIONALE: Estrogen can stimulate the growth of breast cancer cells.NCT00075764·Anniston, Alabama and 425 others

CompletedSupport Program for Adoption of Cancer Screening Interventions at a Rural Community-Based OrganizationThis pilot trial study uses a structural support program for adoption of cancer screening interventions at a rural community-based organization.NCT04208724·Seattle, Washington

TerminatedTherapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast CancerThe purpose of this study is to evaluate the efficacy and safety of an adjuvant treatment of therapeutic cancer vaccine (AST-301, pNGVL3-hICD) in patients with HER2-low expression…NCT05163223·Chandler, Arizona and 16 others

TerminatedTesting the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast CancerThis randomized phase III trial studies how well paclitaxel, trastuzumab, and pertuzumab with or without atezolizumab works in treating patients with breast cancer that has spread…NCT03199885·Birmingham, Alabama and 672 others

CompletedInteractive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA StudyThis trial studies how well an interactive survivorship program works in improving healthcare resources in adolescent and young adult cancer survivors.NCT04593277·Los Angeles, California and 4 others

CompletedOndansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantRATIONALE: Ondansetron may help lessen or prevent nausea and vomiting in patients undergoing stem cell transplant.NCT00795769·Seattle, Washington

CompletedSafety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast CancerThe purpose of this study is to assess safety of nab-paclitaxel based chemotherapy regimens administered prior to and/or in combination with nivolumab in Pancreatic Cancer, Non…NCT02309177·Sacramento, California and 14 others

CompletedLapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.This study will examine safety and efficacy of Lapatinib in combination with a standard neoadjuvant chemotherapy including 5FU, Epirubicin, Cyclophosphamide and Paclitaxel.NCT00524303·Fountain Valley, California and 22 others

RecruitingOnline Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast CancerThis trial tests an online nutrition education program focused on decreasing nutrition-related side effects of chemotherapy in patients with breast cancer.NCT05874297·Seattle, Washington

CompletedA Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast CancerThe primary objective of the study is to assess the progression-free survival (PFS) of veliparib in combination with carboplatin and paclitaxel (C/P) compared to placebo plus C/P…NCT02163694·Gilbert, Arizona and 218 others

CompletedRandomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By ExemestaneTo compare the effects of exemestane for 5 years versus tamoxifen and exemestane given sequentially over 5 years in the adjuvant treatment of postmenopausal women with early…NCT00036270·Bessemer, Alabama and 178 others

CompletedVeliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast CancerThis phase I trial studies the side effects and best dose of veliparib when given together with cisplatin and vinorelbine ditartrate in treating patients with breast cancer that…NCT01104259·Seattle, Washington

CompletedDocetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of breast cancer cells, either by killing the cells or by stopping them from dividing.NCT01547741·Anchorage, Alaska and 914 others

PreviousPage 11 of 28Next

Other Conditions in Seattle

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma